11AM Hour: Exclusive Interviews with the CEOs of Biogen, Novartis & Visa 9/9/26
This episode isn’t summarized yet
Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.
Show notes
Biogen CEO Christopher Viehbacher joins from the Wells Fargo Health Care Conference to discuss the company's drug pipeline and growth outlook. Then, Novartis CEO Vas Narasimhan joins after the company had its third drug trial setback in a week. Plus, we bring you an interview with the CEO of Visa after the company released new data around AI and shopping.
Squawk on the Street Disclaimer
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.